Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients with heart failure, the drive to the effort has demonstrated its safety and its interest. Patients with heart failure, endothelium-dependent peripheral vasodilatation is impaired by decreased activity of endothelial NO synthase. The rehabilitation training significantly improves peripheral endothelial function, and this improvement is correlated to the increase in exercise capacity. The impact on coronary endothelial function remains poorly documented, especially in non-ischemic dilated heart disease.

The main objective of this study is to investigate the effectiveness of cardiac rehabilitation on the restoration of coronary endothelial function in cardiac failure patient evaluated with Tomography Positron Emission 15O-H2O.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiac Rehabilitation of Heart Failure Patients by Telemedicine

NCT00877318

Heart Failure

TERMINATED PHASE4

Effects of Cardiac Telerehabilitation During COVID-19 on Cardiorespiratory Capacities in Coronary Artery Disease Patients.

NCT05749744

Cardiac Disease

COMPLETED

Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

NCT02579954

Pulmonary Arterial Hypertension

COMPLETED NA

Telemonitoring During Phase 2-3 Cardiac Rehabilitation

NCT01252030

Ischemic Heart Disease

COMPLETED PHASE2

Evaluation of Exercise Tolerance and Cardiac Output in Patients With Heart Failure After Intervention of Rehabilitation Program

NCT02928783

Heart Failure With or Without CRT-P/D

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cardiac Rehabilitation

Group Type EXPERIMENTAL

cardiac Rehabilitation

Intervention Type PROCEDURE

Tomography Positron Emission

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cardiac Rehabilitation

Intervention Type PROCEDURE

Tomography Positron Emission

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with heart failure with nonischemic dilated cardiomyopathy
* Class II-III NYHA (New York Heart Association)
* Having no contra-indication to the effort
* Fraction Ejection ≤ 40%
* patient who will have cardiac rehabilitation
* Age over 18 years
* informed consent signed
* patient with a social security scheme

Exclusion Criteria

* Hypertension\> 160/90 mmHg
* High cholesterol level \> 6.0 mmol / l
* Diabetes known and treated
* Active smoking
* Valvular heart disease, congenital or ischemic
* Pregnant or breastfeeding women
* Age \<18 years
* Major Adult guardianship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No